☆ 4.4 Editorial Material

Methotrexate and TNF inhibitors affect long-term immunogenicityto COVID-19 vaccination in patients with immune-mediated inflammatory disease

LANCET RHEUMATOLOGY (2022)

期刊

LANCET RHEUMATOLOGY

卷 4, 期 6, 页码 E384-E387

出版社

ELSEVIER

DOI: 10.1016/S2665-9913(22)00069-8

关键词

-

类别

Rheumatology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Immunology

Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases

Axel Finckh, Adrian Ciurea, Catherine E. Raptis, Andrea Rubbert-Roth

Summary: Immune-mediated inflammatory diseases (IMIDs) are a diverse group of diseases characterized by immune dysregulation, such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis. The prevalence of IMIDs ranges between 5% and 7% in developed countries. The use of immunomodulatory medications in the management of IMIDs can weaken the immune response and increase the risk of severe outcomes from COVID-19, as well as reduce the efficacy of COVID-19 vaccination. This article summarizes the current literature on COVID-19 outcomes, vaccination responses, and the impact of immunomodulatory therapies in patients with rheumatologically dominated IMIDs, and provides vaccination recommendations for individuals with IMID.

JOURNAL OF INFECTIOUS DISEASES (2023)

添加到收藏夹

Article Immunology

Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases

Daniel Mrak, Felix Kartnig, Daniela Sieghart, Elisabeth Simader, Helga Radner, Peter Mandl, Lisa Goeschl, Philipp Hofer, Thomas Deimel, Irina Gessl, Renate Kain, Stefan Winkler, Josef S. Smolen, Thomas Perkmann, Helmuth Haslacher, Daniel Aletaha, Leonhard X. Heinz, Michael Bonelli

Summary: A study found that patients under immunosuppression experienced a rapid decline in antibodies after the third COVID-19 vaccine dose, and it remains unclear whether immunosuppressive therapy affects immune responses. Monitoring the immune response and adverse events in 50 immunosuppressed patients and 42 healthy controls, it was observed that immunosuppressed patients had significantly lower antibody levels, suggesting the need for an early fourth vaccination.

JOURNAL OF AUTOIMMUNITY (2023)

添加到收藏夹

Editorial Material Biochemistry & Molecular Biology

COVID-19 vaccination and immune thrombocytopenia

Allyson M. Pishko, James B. Bussel, Douglas B. Cines

Summary: A study suggests a potential link between the AstraZeneca vaccine and an autoimmune disorder, immune thrombocytopenia, but further research is needed to establish causality.

NATURE MEDICINE (2021)

添加到收藏夹

Review Rheumatology

COVID-19 vaccination and antirheumatic therapy

Jack Arnold, Kevin Winthrop, Paul Emery

Summary: This article discusses the impact of immunosuppressive therapy on COVID-19 vaccination, proposing a suggestion to temporarily suspend treatment to improve vaccine effectiveness, and urging decisions on withholding immunosuppressive therapy to be made in advance without sufficient data support.

RHEUMATOLOGY (2021)

添加到收藏夹

Article Rheumatology

Preferences for COVID-19 Vaccination in People With Chronic Immune-Mediated Inflammatory Diseases

Glen S. Hazlewood, Ines Colmegna, Carol Hitchon, Paul R. Fortin, Sasha Bernatsky, Ann E. Clarke, Dianne Mosher, Todd Wilson, Megan Thomas, Claire E. H. Barber, Mark Harrison, Nick Bansback, Laurie Proulx, Dawn P. Richards, Gilaad G. Kaplan

Summary: This study aimed to understand how people with chronic immune-mediated inflammatory diseases (IMIDs) weigh the benefits and risks of COVID-19 vaccine options. The results showed that vaccine effectiveness, disease flare risk, rare but serious risks, and number/timing of injections were the most important attributes for patients. Overall, patients perceived the benefits of COVID-19 vaccination to outweigh the rare serious risks and disease flare.

JOURNAL OF RHEUMATOLOGY (2023)

添加到收藏夹

Article Emergency Medicine

Severe immune thrombocytopenia following COVID-19 vaccination (Moderna) and immune checkpoint inhibitor

Kah-Meng Chong, Ching-Yao Yang, Chien-Chin Lin, Wan-Ching Lien

Summary: We report a rare case of severe immune thrombocytopenia in an Asian woman following the administration of the Moderna COVID-19 vaccine. This highlights a potential adverse effect of mRNA-based vaccines in cancer patients receiving immune checkpoint inhibitors.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2022)

添加到收藏夹

Article Hematology

Prothrombotic immune thrombocytopenia after COVID-19 vaccination

Andreas Tiede, Ulrich J. Sachs, Andreas Czwalinna, Sonja Werwitzke, Rolf Bikker, Joachim K. Krauss, Frank Donnerstag, Karin Weissenborn, Gunter Hoeglinger, Benjamin Maasoumy, Heiner Wedemeyer, Arnold Ganser

Summary: This study reports 5 cases of prothrombotic immune thrombocytopenia following vaccination with AZD1222. Patients presented with various clinical manifestations, including thrombocytopenia and elevated D-dimer levels. Treatment experience suggests that anticoagulation may be effective, but there is also a risk of unusual and severe thromboembolic events.

BLOOD (2021)

添加到收藏夹

Review Immunology

Interleukin-1 Inhibitors and Vaccination Including COVID-19 in Inflammatory Rheumatic Diseases: A Nonsystematic Review

Pamir Ataguenduez, Goekhan Keser, Mehmet Soy

Summary: New variants of SARS-CoV-2 have raised concerns about the spread of COVID-19, particularly among patients with autoimmune/autoinflammatory rheumatic diseases (AIIRD). The timing of COVID-19 vaccination in AIIRD patients using Interleukin-1 (IL-1) blockers is still a topic of debate.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis

Atsushi Sakuraba, Alexander Luna, Dejan Micic

Summary: The meta-analysis showed that patients with immune-mediated inflammatory diseases have a reduced response to mRNA COVID-19 vaccines, especially those receiving anti-CD20 and anti-tumor necrosis factor therapy. These patients are less likely to achieve a serologic response even after completing the full vaccine series.

GASTROENTEROLOGY (2022)

添加到收藏夹

Article Oncology

COVID-19 vaccination associated severe immune thrombocytopenia

Syed Raza Ali Shah, Sherpa Dolkar, Jacob Mathew, Prakash Vishnu

Summary: This study reports three cases of severe immune thrombocytopenia (ITP) following COVID-19 vaccination and their clinical course. Treatment with oral immunoglobulin and dexamethasone resulted in improvement in platelet counts for all cases, indicating a potential effective management approach for vaccine-induced ITP.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Article Rheumatology

Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls

Felix Kartnig, Daniel Mrak, Elisabeth Simader, Selma Tobudic, Helga Radner, Peter Mandl, Lisa Goeschl, Nikolaus Hommer, Margareta Mayer, Philipp Hofer, Thomas Hummel, Thomas Deimel, Irina Gessl, Antonia Puchner, Andreas Kerschbaumer, Renate Thalhammer, Alessandra Handisurya, Renate Kain, Stefan Winkler, Josef S. Smolen, Karin Stiasny, Thomas Perkmann, Helmuth Haslacher, Judith H. Aberle, Daniel Aletaha, Leonhard X. Heinz, Daniela Sieghart, Michael Bonelli

Summary: This clinical trial evaluated the immunogenicity and safety of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases (IMIDs). The results showed that the third vaccination had good immunogenicity and safety in these patients, but the effects of immunomodulatory therapy should be considered.

ANNALS OF THE RHEUMATIC DISEASES (2023)

添加到收藏夹

Article Pediatrics

The safety of COVID-19 vaccination in immunocompromised children and young adults with immune-mediated inflammatory disease

Benjamin Sahn, Ying Lu, Joyce S. S. Hui-Yuen, Joanna Fishbein, Beth S. S. Gottlieb, Barbara A. A. Eberhard, Heather M. M. Walters

Summary: This study aimed to assess the safety of COVID-19 vaccination in paediatric patients with immune-mediated inflammatory disease (IMID). The results showed that the observed side effects were mild and disease flare rates were low following COVID-19 vaccination in this cohort.

ACTA PAEDIATRICA (2023)

添加到收藏夹

Article Immunology

Autoimmune inflammatory rheumatic diseases post-COVID-19 vaccination

Azam Safary, Kamal Esalatmanesh, Amir Taher Eftekharsadat, Mohammad -Reza Jafari Nakjavani, Alireza Khabbazi

Summary: Vaccination against COVID-19 is important for achieving herd immunity and controlling the pandemic. However, a small number of people may develop autoimmune rheumatic diseases (ARDs) as a rare adverse reaction to the vaccines. This study identifies individuals who developed de-novo ARDs after COVID-19 vaccination, with a higher prevalence among those who received the AstraZeneca vaccine. Prompt diagnosis and treatment can prevent irreversible organ damage.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Immune-Mediated Inflammatory Responses of Alveolar Epithelial Cells: Implications for COVID-19 Lung Pathology

Amelia Barilli, Rossana Visigalli, Francesca Ferrari, Massimiliano G. Bianchi, Valeria Dall'Asta, Bianca Maria Rotoli

Summary: This study found that exposure to supernatants from S1-activated macrophages caused A549 cells to release inflammatory mediators, with massive concentrations of IL-8. Molecular pathway analyses revealed the involvement of NF-kB in the transcription of IP-10 and RANTES, and that STATs drive the expression of various cytokines/chemokines, except for IL-8 which is regulated by AP-1. The cytokines/chemokines produced by spike-activated macrophages may contribute to dysfunction in barrier integrity of alveolar epithelial cells.

BIOMEDICINES (2022)

添加到收藏夹

Article Rheumatology

Immunogenicity 6 months post COVID-19 mRNA vaccination among adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors

Dimitra Dimopoulou, Maria N. Tsolia, Nikos Spyridis, Despoina N. Maritsi

Summary: This study evaluated the immunogenicity in adolescents with JIA on TNFi treatment after receiving the BNT162b2-COVID-19 vaccine. The results showed satisfactory immunogenicity at 1 month and 3 months post-vaccination, but a significant decrease in antibody levels was observed at 6 months. Further research is needed to determine the long-term immunogenicity and the need for booster vaccines.

RHEUMATOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

A Simple Emergency Department-Based Score Predicts Complex Hospitalization in Patients with Inflammatory Bowel Disease

Abhishek Verma, Sanskriti Varma, Daniel E. Freedberg, Jordan E. Axelrad

Summary: This study identified factors such as tachycardia, hypotension, hypoalbuminemia, Clostridioides difficile infection, and endoscopic colitis as predictors of prolonged hospitalization, inpatient colectomy, or salvage therapy in IBD patients with flare. An emergency department-based score utilizing heart rate and albumin level effectively predicted complex hospitalization, providing prognosis in patient care during uncertain times.

DIGESTIVE DISEASES AND SCIENCES (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Long-Term Outcomes of the Excluded Rectum in Crohn's Disease: A Multicenter International Study

Gassan Kassim, Clara Yzet, Nilendra Nair, Anketse Debebe, Alexa Rendon, Jean-Frederic Colombel, Cindy Traboulsi, David T. Rubin, Annalisa Maroli, Elisabetta Coppola, Michele M. Carvello, Nadat Ben David, Francesca De Lucia, Matteo Sacchi, Silvio Danese, Antonino Spinelli, Meike M. C. Hirdes, Joren Ten Hove, Bas Oldenburg, Aurada Cholapranee, Maxine Riter, Dana Lukin, Ellen Scherl, Esen Eren, Keith S. Sultan, Jordan Axelrad, David B. Sachar

Summary: Few patients with CD who underwent fecal diversion and retained excluded rectums were able to achieve successful reanastomosis in the long-term follow-up. A significant proportion of patients remained symptomatic even with retained rectums.

INFLAMMATORY BOWEL DISEASES (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection

Jordan E. Axelrad, Terry Li, Salam P. Bachour, Takahiro Nakamura, Ravi Shah, Michael C. Sachs, Shannon Chang, David P. Hudesman, Stefan D. Holubar, Amy L. Lightner, Edward L. Barnes, Benjamin L. Cohen, Florian Rieder, Eren Esen, Feza Remzi, Miguel Regueiro, Benjamin Click

Summary: Postoperative recurrence of Crohn's disease is common after ileocecal resection. This dual-center study found that early initiation of an anti-TNF agent within 4 weeks following the surgery can reduce the risk of postoperative recurrence.

INFLAMMATORY BOWEL DISEASES (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop

Jordan E. Axelrad, Raymond K. Cross

Summary: Patients with chronic ulcerative and Crohn's colitis have a higher risk of developing colorectal neoplasia (CRN [dysplasia and cancer]) compared to the general population. Risk factors for CRN include the extent of colitis, cumulative inflammatory burden, family history of colorectal cancer, and primary sclerosing cholangitis. Best practices for preventing CRN involve controlling colonic inflammation, conducting high quality surveillance colonoscopy with or without enhanced imaging techniques, removing visible dysplasia if possible, and considering colectomy for patients with unresectable dysplasia, invisible multifocal low-grade dysplasia, or invisible high-grade dysplasia. The decision to stop dysplasia surveillance should be individualized and based on factors such as age, frailty, comorbid conditions, life expectancy, previous surveillance exam results, and risk factors for CRN.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study

Ariela K. Holmer, Jiyu Luo, Kirk B. Russ, Sarah Park, Jeong Yun Yang, Furkan Ertem, Jeffrey Dueker, Vu Nguyen, Simon Hong, Cameron Zenger, Jordan E. Axelrad, Anthony Sofia, Jessica C. Petrov, Badr Al-Bawardy, David I. Fudman, Ernesto Llano, Joseph Dailey, Sushrut Jangi, Nidah Khakoo, Oriana M. Damas, Edward L. Barnes, Frank I. Scott, Ryan C. Ungaro, Siddharth Singh

Summary: A retrospective cohort study compared the safety of TNF-a antagonists and non-TNF biologics in patients with IBD and active or recent cancer. The results showed similar risks of cancer progression and recurrence between the two treatment groups. Therefore, the choice of biologic should be based on IBD disease severity in collaboration with an oncologist.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Histologic Predictors of Clinical Outcomes and Healthcare Utilization in Patients With Ileal Pouch-Anal Anastomosis

Shannon Chang, Simon Hong, David Hudesman, Feza Remzi, Katherine Sun, Wenqing Cao, H. Tarik Kani, Jordan Axelrad, Suparna A. Sarkar

Summary: Histologic variables of acute and chronic inflammation were found to be associated with future development of chronic pouchitis, need for biologic or small molecule treatment for chronic pouchitis, and hospitalization in patients with ileal pouch-anal anastomosis. The study suggests that histologic findings may have predictive value for clinical outcomes and the utilization of healthcare resources in these patients. Incorporation of key histologic variables into pouchoscopy pathology reports and closer monitoring of patients with significant histologic findings may be necessary.

INFLAMMATORY BOWEL DISEASES (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

ECCO Guidelines on Inflammatory Bowel Disease and Malignancies

Hannah Gordon, Livia Biancone, Gionata Fiorino, Konstantinos H. Katsanos, Uri Kopylov, Eman Al Sulais, Jordan E. Axelrad, Karthiha Balendran, Johan Burisch, Lissy de Ridder, Lauranne Derikx, Pierre Ellul, Thomas Greuter, Marietta Iacucci, Caroline Di Jiang, Christina Kapizioni, Konstantinos Karmiris, Julien Kirchgesner, David Laharie, Triana Lobaton, Tamas Molnar, Nurulamin M. Noor, Rohit Rao, Simone Saibeni, Michael Scharl, Stephan R. Vavricka, Tim Raine

JOURNAL OF CROHNS & COLITIS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Pathogen-Specific Alterations in the Gut Microbiota Predict Outcomes in Flare of Inflammatory Bowel Disease Complicated by Gastrointestinal Infection

Jordan E. Axelrad, Ze Chen, Joseph Devlin, Kelly V. Ruggles, Ken Cadwell

Summary: This study found that enteric infection with specific pathogens such as Clostridioides difficile, Escherichia coli subtypes, and norovirus can affect the outcomes of inflammatory bowel disease (IBD). The gut microbiome was associated with the characteristics and outcomes of IBD, and different microbiomes were detected after enteric infections. Clinical variables and 16S rRNA sequencing revealed the impact of the gut microbiome on IBD.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Enteric Infection at Flare of Inflammatory Bowel Disease Impacts Outcomes at 2 Years

Abhishek Dimopoulos-Verma, Soonwook Hong, Jordan E. Axelrad

Summary: This study found that enteric infection during flare, specifically Clostridioides difficile infection, is associated with worse IBD outcomes at 2 years. The relationship between E. coli subtypes at flare and subsequent IBD outcomes requires further investigation.

INFLAMMATORY BOWEL DISEASES (2023)

添加到收藏夹

Article Immunology

Multimodal single-cell datasets characterize antigen-specific CD8+ T cells across SARS-CoV-2 vaccination and infection

Bingjie Zhang, Rabi Upadhyay, Yuhan Hao, Marie I. Samanovic, Ramin S. Herati, John D. Blair, Jordan Axelrad, Mark J. Mulligan, Dan R. Littman, Rahul Satija

Summary: This study analyzed the T cell response after BNT162b2 vaccination using multimodal sequencing technologies. The researchers identified CD8(+) T cell subpopulations and explored their transcriptome, chromatin landscape, and immunophenotype. They also found that the frequency and differentiation outcomes of these CD8(+) T cell subpopulations were predictive of clinical outcomes in COVID-19 patients.

NATURE IMMUNOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Histologic Inflammation can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission

Lauren A. George, Harris T. Feldman, Madeline Alizadeh, Ameer Abutaleb, Samantha Zullow, Ashley Hine, Kristen Stashek, Suparna Sarkar, Katherine Sun, David Hudesman, Jordan Axelrad, Raymond K. Cross

Summary: Patients with ulcerative colitis who have endoscopic improvement have a high risk of clinical relapse over time. Histologic activity, as assessed by the Robarts Histopathologic Index, is predictive of clinical relapse.

CROHNS & COLITIS 360 (2023)

添加到收藏夹

Meeting Abstract Gastroenterology & Hepatology

Predictors of time to relapse upon ozanimod withdrawal in patients with moderately to severely active ulcerative colitis

S. Vermeire, B. Abraham, B. Bressler, W. Reinisch, J. E. Axelrad, A. Jain, A. Memaj, L. Akukwe, W. J. Liu, M. T. Osterman, J. B. Canavan, B. E. Sands

JOURNAL OF CROHNS & COLITIS (2023)

添加到收藏夹

Meeting Abstract Gastroenterology & Hepatology

Efficacy of ozanimod in vedolizumab-exposed patients with ulcerative colitis: a phase 3 True North post hoc analysis

B. E. Sands, A. Jain, H. A. Ahmad, M. Osterman, A. Memaj, J. B. Canavan, J. E. Axelrad

JOURNAL OF CROHNS & COLITIS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease

Katherine L. L. Stone, Emma Kulekofsky, David Hudesman, Samuel Kozloff, Feza Remzi, Jordan E. E. Axelrad, Seymour Katz, Simon J. J. Hong, Ariela Holmer, Mara A. A. McAdams-DeMarco, Dorry L. L. Segev, John Dodson, Aasma Shaukat, Adam S. S. Faye

Summary: This study retrospectively analyzed telehealth visits at the NYU IBD Center from March 1, 2020, to August 31, 2021. The study found that patients with Crohn's disease, females, and those with less social support were more likely to miss telehealth appointments. Additionally, adults over 80 years old were more likely to miss telehealth appointments compared to those aged 60-70 years. Therefore, telehealth may provide an additional venue for older adults, especially those aged 60-80 years, to complement in-person care.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2023)

添加到收藏夹

Meeting Abstract Gastroenterology & Hepatology

GUT MICROBIOME CHANGES ASSOCIATED WITH HIGHER AND LONGER-LASTING ANTIBODY TITERS FOLLOWING COVID-19 VACCINATION

Mericien M. Venzon, Luke Newell, Jonas Schluter, Jordan E. Axelrad

GASTROENTEROLOGY (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.